Patent ID: 11926874
Assignee: DANA-FARBER CANCER INSTITUTE, INC.
Field: Measurement (Instruments)
Classification: CPC C  A  G | IPC C  G

Claim 0:
1. A method for inhibiting hyperproliferative growth of head, neck, or lung cancer cells that express soluble PD-L1 protein consisting of the amino acid sequence of SEQ ID NO: 13, wherein the cancer cells have been determined to express the soluble PD-L1 protein consisting of the amino acid sequence of SEQ ID NO: 13 by assaying a sample of the cancer cells for the presence of the soluble PD-L1 protein consisting of the amino acid sequence of SEQ ID NO: 13, the method comprising contacting the cells with an anti-PD-L1 antibody that blocks the interaction between PD-L1 and PD-1.